Robin L. Wesselschmidt

3.9k total citations · 1 hit paper
33 papers, 3.3k citations indexed

About

Robin L. Wesselschmidt is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Robin L. Wesselschmidt has authored 33 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Hematology and 6 papers in Immunology. Recurrent topics in Robin L. Wesselschmidt's work include Pluripotent Stem Cells Research (10 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and CRISPR and Genetic Engineering (5 papers). Robin L. Wesselschmidt is often cited by papers focused on Pluripotent Stem Cells Research (10 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and CRISPR and Genetic Engineering (5 papers). Robin L. Wesselschmidt collaborates with scholars based in United States, Portugal and Switzerland. Robin L. Wesselschmidt's co-authors include Timothy J. Ley, John H. Russell, Sujan Shresta, Jonathan W. Heusel, Fulu Liu, Tad Kornaga, Daniel C. Link, Dale K. Kobayashi, Steven D. Shapiro and J. Michael Shipley and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Robin L. Wesselschmidt

32 papers receiving 3.2k citations

Hit Papers

Cytotoxic lymphocytes require granzyme B for the rapid in... 1994 2026 2004 2015 1994 200 400 600

Peers

Robin L. Wesselschmidt
Stephen J. Brandt United States
Dominic Cosgrove United States
E. Camilla Forsberg United States
Linda A. Cannizzaro United States
D. Wade Clapp United States
Deborah L. Galson United States
Robin L. Wesselschmidt
Citations per year, relative to Robin L. Wesselschmidt Robin L. Wesselschmidt (= 1×) peers Rupert Hallmann

Countries citing papers authored by Robin L. Wesselschmidt

Since Specialization
Citations

This map shows the geographic impact of Robin L. Wesselschmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin L. Wesselschmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin L. Wesselschmidt more than expected).

Fields of papers citing papers by Robin L. Wesselschmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin L. Wesselschmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin L. Wesselschmidt. The network helps show where Robin L. Wesselschmidt may publish in the future.

Co-authorship network of co-authors of Robin L. Wesselschmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Robin L. Wesselschmidt. A scholar is included among the top collaborators of Robin L. Wesselschmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin L. Wesselschmidt. Robin L. Wesselschmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wood, Deborah, Robin L. Wesselschmidt, Peiman Hematti, et al.. (2014). An Update from the United States National Heart, Lung, and Blood Institute‐funded Production Assistance for Cellular Therapies (PACT) Program: A Decade of Cell Therapy. Clinical and Translational Science. 7(2). 93–99. 5 indexed citations
2.
Wesselschmidt, Robin L., et al.. (2014). Cellular Therapies Clinical Research Roadmap: lessons learned on how to move a cellular therapy into a clinical trial. Cytotherapy. 17(4). 339–343. 3 indexed citations
3.
Liu, Yongxing, et al.. (2012). Modified Hyaluronan Hydrogels Support the Maintenance of Mouse Embryonic Stem Cells and Human Induced Pluripotent Stem Cells. Macromolecular Bioscience. 12(8). 1034–1042. 24 indexed citations
4.
Schwartz, Philip H. & Robin L. Wesselschmidt. (2011). Human Pluripotent Stem Cells. Methods in molecular biology. 14 indexed citations
5.
Wesselschmidt, Robin L. & Philip H. Schwartz. (2011). The Stem Cell Laboratory: Design, Equipment, and Oversight. Methods in molecular biology. 767. 3–13. 5 indexed citations
6.
Mao, Changhui, Miao Wang, Biquan Luo, et al.. (2010). Targeted Mutation of the Mouse Grp94 Gene Disrupts Development and Perturbs Endoplasmic Reticulum Stress Signaling. PLoS ONE. 5(5). e10852–e10852. 68 indexed citations
7.
Kim, Eun‐Hae, Victoria R. Rendell, Lubov Ezerskiy, et al.. (2009). Mu and kappa opioids modulate mouse embryonic stem cell‐derived neural progenitor differentiation via MAP kinases. Journal of Neurochemistry. 112(6). 1431–1441. 36 indexed citations
8.
Lyu, Jungmook, Robin L. Wesselschmidt, & Wange Lu. (2009). Cdc37 Regulates Ryk Signaling by Stabilizing the Cleaved Ryk Intracellular Domain. Journal of Biological Chemistry. 284(19). 12940–12948. 25 indexed citations
9.
Milewski, Wieslawa, Karla A. Temple, Robin L. Wesselschmidt, & Manami Hara. (2008). Generation of embryonic stem cells from mouse insulin I promoter-green fluorescent protein transgenic mice and characterization in a teratoma model. In Vitro Cellular & Developmental Biology - Animal. 45(1-2). 1–5. 5 indexed citations
10.
Clark, Amy L., et al.. (2006). μ- and κ-Opioids Induce the Differentiation of Embryonic Stem Cells to Neural Progenitors. Journal of Biological Chemistry. 281(44). 33749–33760. 74 indexed citations
11.
Graubert, Timothy A., Bruce A. Hug, Robin L. Wesselschmidt, et al.. (1998). Stochastic, stage-specific mechanisms account for the variegation of a human globin transgene. Nucleic Acids Research. 26(12). 2849–2858. 39 indexed citations
12.
Shresta, Sujan, et al.. (1997). Residual Cytotoxicity and Granzyme K Expression in Granzyme A-deficient Cytotoxic Lymphocytes. Journal of Biological Chemistry. 272(32). 20236–20244. 47 indexed citations
14.
Shresta, Sujan, Jonathan W. Heusel, Debra M. MacIvor, et al.. (1995). Granzyme B Plays a Critical Role in Cytotoxic Lymphocyte‐induced Apoptosis. Immunological Reviews. 146(1). 211–221. 63 indexed citations
15.
Lee, Stephen, et al.. (1995). Growth and Differentiation Proceeds Normally in Cells Deficient in the Immediate Early Gene NGFI-A. Journal of Biological Chemistry. 270(17). 9971–9977. 151 indexed citations
16.
Lee, Stephen, Robin L. Wesselschmidt, Gerald P. Linette, et al.. (1995). Unimpaired Thymic and Peripheral T Cell Death in Mice Lacking the Nuclear Receptor NGFI-B (Nur77). Science. 269(5223). 532–535. 234 indexed citations
17.
Heusel, Jonathan W., Robin L. Wesselschmidt, Sujan Shresta, John H. Russell, & Timothy J. Ley. (1994). Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell. 76(6). 977–987. 721 indexed citations breakdown →
18.
Broze, George, Robin L. Wesselschmidt, Darryl A. Higuchi, et al.. (1992). The Interaction Between LACI and Heparin. Advances in experimental medicine and biology. 313. 189–197. 3 indexed citations
19.
Wesselschmidt, Robin L., Thomas Girard, & George Broze. (1990). cDNA sequence of rabbit lipoprotein-associated coagulation inhibitor. Nucleic Acids Research. 18(21). 6440–6440. 11 indexed citations
20.
Freire-Moar, José, Harold W. Schnaper, Randolph V. Lewis, et al.. (1990). Putative N-terminal sequence of murine soluble immune response suppressor (SIRS): significant homology with short neurotoxin 1. International Immunology. 2(8). 765–774. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026